ATE192339T1 - Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln - Google Patents

Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln

Info

Publication number
ATE192339T1
ATE192339T1 AT93904187T AT93904187T ATE192339T1 AT E192339 T1 ATE192339 T1 AT E192339T1 AT 93904187 T AT93904187 T AT 93904187T AT 93904187 T AT93904187 T AT 93904187T AT E192339 T1 ATE192339 T1 AT E192339T1
Authority
AT
Austria
Prior art keywords
diagnostic
pct
therapeutic agents
fullerene derivatives
sec
Prior art date
Application number
AT93904187T
Other languages
English (en)
Inventor
Alan D Watson
Jo Klaveness
Gene C Jamieson
Jere Douglas Fellmann
Nils Blane Vogt
Julian R M Cockbain
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Application granted granted Critical
Publication of ATE192339T1 publication Critical patent/ATE192339T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1268—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/189—Host-guest complexes, e.g. cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/228—Host-guest complexes, clathrates, chelates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acoustics & Sound (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
AT93904187T 1992-02-11 1993-02-11 Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln ATE192339T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203037A GB9203037D0 (en) 1992-02-11 1992-02-11 Contrast agents
PCT/GB1993/000279 WO1993015768A1 (en) 1992-02-11 1993-02-11 Use of fullerenes in diagnostic and/or therapeutic agents

Publications (1)

Publication Number Publication Date
ATE192339T1 true ATE192339T1 (de) 2000-05-15

Family

ID=10710315

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93904187T ATE192339T1 (de) 1992-02-11 1993-02-11 Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln

Country Status (8)

Country Link
US (1) US5688486A (de)
EP (1) EP0625055B1 (de)
JP (1) JPH07506092A (de)
AT (1) ATE192339T1 (de)
AU (1) AU3506893A (de)
DE (1) DE69328550T2 (de)
GB (1) GB9203037D0 (de)
WO (1) WO1993015768A1 (de)

Families Citing this family (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
CA2144051A1 (en) * 1992-09-08 1994-03-17 Klaus-Dieter Kampe New fullerene derivatives, method of synthesizing them and their use
DE4339053A1 (de) * 1992-12-15 1994-06-16 Franz Dietrich Oeste Mit Wirkstoffen gefüllte Spheren, Verfahren zu ihrer Herstellung und Öffnung
EP0722291A1 (de) * 1993-10-04 1996-07-24 Mallinckrodt Medical, Inc. Verfahren und verbindungen zur bilderzeugung mittels magnetischer kernresonanz und röntgentechnik sowie radioaktive arzneimittel
US5866434A (en) * 1994-12-08 1999-02-02 Meso Scale Technology Graphitic nanotubes in luminescence assays
WO1996024139A2 (en) * 1995-01-23 1996-08-08 Schaefer Daniel R Trapping and storage of free thermal neutrons in fullerene molecules
EP0890114A1 (de) * 1996-03-29 1999-01-13 Lawrence Berkeley National Laboratory Verbesserung von kermagnetischer resonanz und bilderzeugung durch kermagnetische resonanz im beisein von hyperpolarisierten edelgasen
US6736769B2 (en) 1996-04-17 2004-05-18 Olivier Bertrand Radioactivity local delivery system
US5871436A (en) * 1996-07-19 1999-02-16 Advanced Cardiovascular Systems, Inc. Radiation therapy method and device
US5782740A (en) * 1996-08-29 1998-07-21 Advanced Cardiovascular Systems, Inc. Radiation dose delivery catheter with reinforcing mandrel
US6210312B1 (en) 1997-05-20 2001-04-03 Advanced Cardiovascular Systems, Inc. Catheter and guide wire assembly for delivery of a radiation source
WO1999004826A1 (en) * 1997-07-24 1999-02-04 The Australian National University Method for detection of fibrin clots
WO1999032184A1 (en) * 1997-12-19 1999-07-01 Cordis Corporation Catheter system having fullerenes and method
US6159140A (en) * 1998-02-17 2000-12-12 Advanced Cardiovascular Systems Radiation shielded catheter for delivering a radioactive source and method of use
US6159139A (en) * 1998-02-17 2000-12-12 Advanced Cardiovascular Systems Inc. Radiation delivery catheter with a spring wire centering mechanism
DE19816917A1 (de) * 1998-04-16 1999-10-28 Siemens Ag Verfahren zur räumlich aufgelösten Temperaturüberwachung, Suspension von ferromagnetischen Mikropartikeln und Verwendung dieser Suspension
GB2337050B (en) * 1998-05-04 2001-02-14 Chinese Petroleum Corp Fullerene-containing metallocene
WO2000006244A2 (en) * 1998-07-30 2000-02-10 Hainfeld James F Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy
US6355224B1 (en) * 1998-09-17 2002-03-12 Massachusetts Institute Of Technology Conductive polymer contrast agent compositions and uses therefor
US6203778B1 (en) * 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
US20030073250A1 (en) * 1999-05-21 2003-04-17 Eric Henderson Method and apparatus for solid state molecular analysis
US6573369B2 (en) * 1999-05-21 2003-06-03 Bioforce Nanosciences, Inc. Method and apparatus for solid state molecular analysis
US20020042081A1 (en) * 2000-10-10 2002-04-11 Eric Henderson Evaluating binding affinities by force stratification and force panning
US20030186311A1 (en) * 1999-05-21 2003-10-02 Bioforce Nanosciences, Inc. Parallel analysis of molecular interactions
US6562295B1 (en) * 1999-06-30 2003-05-13 Ceramoptec Industries, Inc. Bacteria resistant medical devices
DE19936997B4 (de) * 1999-08-02 2007-06-14 Biolitec Ag Verfahren zur Applikation von Photosensibilisatoren (PS) mittels Multiplikatoren in der photodymamischen Therapie
US6582417B1 (en) 1999-09-22 2003-06-24 Advanced Cardiovascular Systems, Inc. Methods and apparatuses for radiation treatment
US6605031B1 (en) 1999-09-22 2003-08-12 Advanced Cardiovascular Systems, Inc. Stepped centering balloon for optimal radiation delivery
US6355225B1 (en) * 1999-10-05 2002-03-12 Wm. Marsh Rice University Tda Research, Inc. Fullerene contrast agent for magnetic resonance imaging and spectroscopy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6540734B1 (en) 2000-02-16 2003-04-01 Advanced Cardiovascular Systems, Inc. Multi-lumen extrusion tubing
US7994449B2 (en) 2000-02-16 2011-08-09 Advanced Cardiovascular Systems, Inc. Square-wave laser bonding
US6897015B2 (en) * 2000-03-07 2005-05-24 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of pathogens and biological materials
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
US8460367B2 (en) * 2000-03-15 2013-06-11 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20070055367A1 (en) * 2000-03-15 2007-03-08 Orbus Medical Technologies, Inc. Medical device with coating that promotes endothelial cell adherence and differentiation
ATE362382T1 (de) * 2000-03-15 2007-06-15 Orbusneich Medical Inc Beschichtung welche ein anhaften von endothelzellen stimuliert
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US6471942B1 (en) 2000-04-20 2002-10-29 Luna Innovations, Inc. Imaging and treatment method for body
AU2001263762A1 (en) * 2000-05-02 2001-11-12 Hahn-Meitner-Institut Berlin Gmbh Molecular arrangement with a structural configuration and use thereof for quantum-mechanical information processing
AU2000246082A1 (en) * 2000-05-21 2001-12-03 Transscan Medical Ltd. Apparatus for impedance imaging coupled with another modality
US20030165431A1 (en) * 2000-07-13 2003-09-04 The Regents Of The University Of California Method for detecting macromolecular conformational change and binding information
US6652833B2 (en) * 2000-07-13 2003-11-25 The Regents Of The University Of California Functionalized active-nucleus complex sensor
US7061237B2 (en) * 2000-07-13 2006-06-13 The Regents Of The University Of California Remote NMR/MRI detection of laser polarized gases
AU2002245009B2 (en) * 2000-08-15 2007-05-17 Bioforce Nanoscience, Inc. Nanoscale molecular arrayer
US6660248B2 (en) 2000-11-10 2003-12-09 William Marsh Rice University Fullerene (C60)-based X-ray contrast agent for diagnostic imaging
US20020177769A1 (en) * 2001-04-23 2002-11-28 The Regents Of The University Of California Method and apparatus for locating cells in the body by measuring magnetic moments
US20040038946A1 (en) * 2001-04-27 2004-02-26 Wilson Lon J. Fullerene-based drugs targeted to bone
US6878361B2 (en) * 2001-07-10 2005-04-12 Battelle Memorial Institute Production of stable aqueous dispersions of carbon nanotubes
WO2003008941A2 (en) * 2001-07-17 2003-01-30 Bioforce Nanosciences, Inc. Combined molecular blinding detection through force microscopy and mass spectrometry
US20040156852A1 (en) * 2003-02-06 2004-08-12 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles
US7042488B2 (en) 2001-09-27 2006-05-09 Fujinon Corporation Electronic endoscope for highlighting blood vessel
US7812190B2 (en) * 2001-10-01 2010-10-12 Tda Research, Inc. Derivatization and solubilization of fullerenes for use in therapeutic and diagnostic applications
US7671230B2 (en) 2001-10-01 2010-03-02 Tda Research, Inc. Derivatization and solubilization of insoluble classes of fullerenes
US20030135195A1 (en) * 2002-01-16 2003-07-17 Oscar Jimenez Highly lubricious hydrophilic coating utilizing dendrimers
ES2233118B1 (es) * 2002-01-30 2006-07-16 Francisco Leon Prieto Sistema de administracion no intravenosa de un ligando especifico de celulas de epitelios, detectable por tecnicas de imagen y sus aplicaciones.
US20080193490A1 (en) * 2002-02-14 2008-08-14 Andreas Hirsch Use of Carbon Nanotube for Drug Delivery
US20040166152A1 (en) * 2002-02-14 2004-08-26 Andreas Hirsch Use of buckysome or carbon nanotube for drug delivery
TW200307563A (en) * 2002-02-14 2003-12-16 Sixty Inc C Use of BUCKYSOME or carbon nanotube for drug delivery
EP1494584A4 (de) * 2002-04-02 2009-02-04 Virginia Tech Intell Prop Endohedrale metallofulleren-kontrastmittel
JP4667705B2 (ja) * 2002-04-26 2011-04-13 三菱電機株式会社 磁気的相互作用算出プログラム
US20050239193A1 (en) * 2002-05-30 2005-10-27 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of microorganisms and microparticles
AU2003248679A1 (en) * 2002-06-14 2003-12-31 Actinium Pharmaceuticals Ltd. Treating disease using radium-225
EP1517684B1 (de) 2002-06-27 2009-07-22 Health Research, Inc. Fluorinierte chlorin und bacteriochlorin photosensitizer für fotodynamische therapie
US20040058457A1 (en) * 2002-08-29 2004-03-25 Xueying Huang Functionalized nanoparticles
US20040092807A1 (en) * 2002-11-07 2004-05-13 Amos Breskin System and method for cancer detection
JP2006512583A (ja) * 2003-01-02 2006-04-13 バイオフォース ナノサイエンシズ インコーポレイテッド 小サンプル体積における分子分析の方法及び装置
US20040156846A1 (en) * 2003-02-06 2004-08-12 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles using L6 antibodies
KR100513089B1 (ko) * 2003-09-23 2005-09-08 광주과학기술원 풀러렌계 나노구 및 그 제조방법
US20050288236A1 (en) * 2003-10-10 2005-12-29 Russ Lebovitz Substituted fullerene formulations and their use in ameliorating oxidative stress diseases or inhibiting cell death
US20060247152A1 (en) * 2005-05-02 2006-11-02 Russ Lebovitz Substituted fullerenes and their use as inhibitors of cell death
KR100977697B1 (ko) * 2003-10-10 2010-08-24 도쿠리쓰교세이호징 가가쿠 기주쓰 신코 기코 탄소 화합물이 봉입된 미소 입자의 복합체
GB2413182A (en) * 2004-04-16 2005-10-19 Univ Southampton An NMR method for analysing a sample
WO2005107817A2 (en) * 2004-04-30 2005-11-17 Orbus Medical Technologies, Inc. Medical device with coating for capturing genetically-altered cells and methods of using same
US20060039521A1 (en) 2004-06-22 2006-02-23 Schaefer Daniel R Direct production of thermal antineutrons and antiprotons
US20060051290A1 (en) * 2004-07-13 2006-03-09 William Marsh Rice University Short carbon nanotubes as adsorption and retention agents
US20060280785A1 (en) * 2004-08-11 2006-12-14 Easterly Clay E Biocidal materials for treatment against pathogens
WO2006028635A2 (en) * 2004-09-02 2006-03-16 C Sixty Inc. Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis
JP4822702B2 (ja) * 2004-12-24 2011-11-24 独立行政法人科学技術振興機構 造影剤
US20060140867A1 (en) * 2004-12-28 2006-06-29 Helfer Jeffrey L Coated stent assembly and coating materials
CA2590386A1 (en) * 2004-12-30 2006-07-06 Cinvention Ag Combination comprising an agent providing a signal, an implant material and a drug
DE602005010747D1 (de) 2005-01-13 2008-12-11 Cinv Ag Kohlenstoffnanopartikel enthaltende verbundwerkstoffe
DE102005005704B4 (de) * 2005-02-03 2010-08-12 Leibniz-Institut Für Festkörper- Und Werkstoffforschung Dresden E.V. Verwendung von Partikeln für die Ermittlung der lokalen Temperatur in organischen und nichtorganischen Körpern
DE102005007223B4 (de) * 2005-02-15 2009-01-02 Helmholtz-Zentrum Berlin Für Materialien Und Energie Gmbh Verwendung eines endohedrale Fullerene enthaltendes Kontrastmittel für die Kernspintomographie unter Nutzung des Overhauser-Effekts
WO2006116021A2 (en) * 2005-04-22 2006-11-02 Intematix Corporation Mri technique based on electron spin resonance and endohedral contrast agent
EP1877105B1 (de) * 2005-04-29 2013-08-14 The Australian National University Verfahren zur bildung einer injizierbaren radioaktiven zusammensetzung aus einer in kohlenstoff eingeschlossenen radioaktiven partikulären substanz
US8246917B2 (en) 2006-06-23 2012-08-21 Johns Hopkins University Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
WO2007014113A2 (en) 2005-07-22 2007-02-01 Johns Hopkins University Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers
WO2008108862A2 (en) * 2006-06-23 2008-09-12 Johns Hopkins University Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery
US20070025918A1 (en) * 2005-07-28 2007-02-01 General Electric Company Magnetic resonance imaging (MRI) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization
EP1937753A1 (de) * 2005-10-18 2008-07-02 Cinvention Ag Duroplastische teilchen und herstellungsverfahren dafür
US20080020977A1 (en) * 2005-11-21 2008-01-24 Russ Lebovitz Use of Fullerenes to Oxidize Reduced Redox Proteins
US10835355B2 (en) 2006-04-20 2020-11-17 Sonendo, Inc. Apparatus and methods for treating root canals of teeth
EP2015698B1 (de) 2006-04-20 2017-11-15 Sonendo, Inc. Gerät zur behandlung von zahnwurzelkanälen
WO2007137256A2 (en) * 2006-05-22 2007-11-29 William Marsh Rice University Carbon nanotube based imaging agents
ATE524197T1 (de) * 2006-05-25 2011-09-15 Univ Wake Forest Health Sciences Hyperthermische techniken und ihre therapeutische anwendung
WO2007143558A1 (en) * 2006-06-01 2007-12-13 William Marsh Rice University Targeted nanostructures for cellular imaging
US7980854B2 (en) 2006-08-24 2011-07-19 Medical Dental Advanced Technologies Group, L.L.C. Dental and medical treatments and procedures
US20080070195A1 (en) * 2006-08-24 2008-03-20 Divito Enrico E Energetically activated biomedical nanotheurapeutics integrating dental and medical treatments and procedures
US20100330539A1 (en) * 2006-08-24 2010-12-30 Medical Dental Advance Technologies Group Periodontal treatment system and method
CA2675121A1 (en) * 2007-01-19 2008-07-24 Cinvention Ag Porous, non-degradable implant made by powder molding
US20080206862A1 (en) * 2007-02-28 2008-08-28 Cinvention Ag High surface cultivation system bag
BRPI0808049A2 (pt) * 2007-02-28 2014-06-24 Cinv Ag Sistema de cultivo de alta superfície com enchedor
AU2008220791A1 (en) * 2007-02-28 2008-09-04 Cinvention Ag High surface cultivation system with surface increasing substrate
CN101646764A (zh) * 2007-02-28 2010-02-10 金文申有限公司 高表面积培养系统
WO2008154043A2 (en) * 2007-06-14 2008-12-18 The Board Of Trustees Of The University Of Arkansas Near-infrared responsive carbon nanostructures
WO2009059215A1 (en) * 2007-10-31 2009-05-07 University Of Florida Research Foundation, Inc. Use of fullerenes in photoacoustic imaging
US8187221B2 (en) * 2008-07-11 2012-05-29 Nexeon Medsystems, Inc. Nanotube-reinforced balloons for delivering therapeutic agents within or beyond the wall of blood vessels, and methods of making and using same
GB0820309D0 (en) * 2008-11-06 2008-12-17 Middlesex University Higher Ed Detection of cancer
DE102008043654A1 (de) * 2008-11-11 2010-05-20 Leibniz-Institut Für Festkörper- Und Werkstoffforschung Dresden E.V. Diagnostisches und/oder therapeutisches Agens, Verfahren zu seiner Herstellung und Verwendung
JP5463548B2 (ja) * 2009-09-08 2014-04-09 学校法人福岡大学 超音波治療用リポソーム及び超音波治療促進用リポソーム
JP5902096B2 (ja) 2009-11-13 2016-04-13 ソネンド インコーポレイテッド 歯科治療のための液体噴射装置および方法
US9125942B2 (en) * 2010-01-19 2015-09-08 Northwestern University Paramagnetic metal-nanodiamond conjugates
DE102010020567A1 (de) * 2010-05-14 2011-11-17 Merck Patent Gmbh Metallkomplexe
US20120052008A1 (en) * 2010-08-25 2012-03-01 Yuri Mackeyev Nanostructures comprising radioisotopes and/or metals
US8888879B1 (en) 2010-10-20 2014-11-18 Us Synthetic Corporation Detection of one or more interstitial constituents in a polycrystalline diamond element by neutron radiographic imaging
EP2629693B1 (de) 2010-10-21 2020-08-26 Sonendo, Inc. Vorrichtung für endodontische behandlungen
US9085463B2 (en) 2011-01-17 2015-07-21 Marelle, Llc Water-soluble functionalized fullerenes
US20140161733A1 (en) * 2011-03-30 2014-06-12 Luna Innovations Incorporated Biomarker-targeting contrast agents and their use in magnetic resonance imaging for detection of atherosclerotic plaque
CA2867703A1 (en) 2012-03-22 2013-09-26 Sonendo, Inc. Apparatus and methods for cleaning teeth
US10631962B2 (en) 2012-04-13 2020-04-28 Sonendo, Inc. Apparatus and methods for cleaning teeth and gingival pockets
WO2014100751A1 (en) 2012-12-20 2014-06-26 Sonendo, Inc. Apparatus and methods for cleaning teeth and root canals
US10363120B2 (en) 2012-12-20 2019-07-30 Sonendo, Inc. Apparatus and methods for cleaning teeth and root canals
WO2014179619A2 (en) 2013-05-01 2014-11-06 Sonendo, Inc. Apparatus and methods for treating teeth
EP3013277B1 (de) 2013-06-26 2023-07-19 Sonendo, Inc. Vorrichtung und verfahren zum füllen von zähnen und zahnwurzelkanälen
KR101612514B1 (ko) * 2014-06-16 2016-04-14 포항공과대학교 산학협력단 에멀젼을 이용한 탄소 양자점의 제조 방법
US10806544B2 (en) 2016-04-04 2020-10-20 Sonendo, Inc. Systems and methods for removing foreign objects from root canals
CN109096118B (zh) * 2017-06-21 2021-07-30 北京福纳康生物技术有限公司 胺基富勒烯衍生物及其制备方法和应用
USD997355S1 (en) 2020-10-07 2023-08-29 Sonendo, Inc. Dental treatment instrument

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122363A (en) * 1990-12-07 1992-06-16 Board Of Regents, The University Of Texas System Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
US5177248A (en) * 1991-10-28 1993-01-05 Exxon Research And Engineering Company Process of forming polysubstituted fullerenes

Also Published As

Publication number Publication date
US5688486A (en) 1997-11-18
WO1993015768A1 (en) 1993-08-19
GB9203037D0 (en) 1992-03-25
EP0625055B1 (de) 2000-05-03
EP0625055A1 (de) 1994-11-23
DE69328550T2 (de) 2001-02-08
DE69328550D1 (de) 2000-06-08
AU3506893A (en) 1993-09-03
JPH07506092A (ja) 1995-07-06

Similar Documents

Publication Publication Date Title
ATE192339T1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
ATE319823T1 (de) Bmp-12, bmp-13 und diese enthaltende sehne- induzierende zusammensetzungen
KR900009079A (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
DE68919146D1 (de) Ausgewählte Stämme von Lactobacillus enthaltende pharmazeutische Zusammensetzungen.
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
FI935306A (fi) Puhdistettujen, pintaa modifioivien aineiden käyttö estämään hiukkasten kasautumista steriloinnin aikana
CY1111863T1 (el) Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
EE9800223A (et) Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
NO942720L (no) 1,5-benzobiazepinderivater og medisinsk anvendelse av disse
DK0396404T3 (da) Farmaceutisk middel indeholdende loratadin, ibuprofen og pseudoephedrin
YU26691A (sh) BORNO KISELINSKI ADUKTI RENIJUM DIOKSIM I TEHNICIJUM-99 m DIOKSIM KOMPLEKSA I PRIBOR ZA MARKIRANJE SA TEHNICIJUMOM 99 m I/ILI RADIONUKLEIDOM RENIJUMA
ATE185066T1 (de) Lösung zur verwendung gegen den pilzbefall von nägeln
DE69813839D1 (de) Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
DE69429536D1 (de) Analgetisches Mittel und dessen Verwendung
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DK7191D0 (da) Topisk salve
GR1001151B (el) Νεα xρηση θειορεδοξινης
DE69319337D1 (en) Polyetheramidoamine hydrogele als heparinersatz
DK0478631T3 (da) Målsøgende midler
DE69129693D1 (de) Verwendung von nickel und bromide ionen für die behandlung von psoriasis
DE69427116D1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties